Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
PURPOSE OF REVIEW: To examine the current evidence concerning the effects of genetic variation on statin-related low-density lipoprotein cholesterol reductions, clinical efficacy, and adverse events and the relevance for patient care. RECENT FINDINGS: Recent years have seen the emergence of large-sc...
Автори: | Hopewell, J, Reith, C, Armitage, J |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Lippincott Williams and Wilkins
2014
|
Схожі ресурси
Схожі ресурси
-
Interpretation of the evidence for the efficacy and safety of statin therapy
за авторством: Collins, R, та інші
Опубліковано: (2016) -
Safety and efficacy of statins - Authors' reply
за авторством: Collins, R, та інші
Опубліковано: (2017) -
Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
за авторством: Cholesterol Treatment Trialists' Collaboration, та інші
Опубліковано: (2019) -
Pharmacogenomics Statins: Biomarkers for Clinical Prediction
за авторством: Herni Suprapti
Опубліковано: (2018-09-01) -
The safety of statins in clinical practice.
за авторством: Armitage, J
Опубліковано: (2007)